Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Disease × Patient Positioning × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 1 Pain 1 Neoplasms 1 Disease 1 Breast Neoplasms 1 Breakthrough Pain 1

Interventions

Magnetic Resonance Spectroscopy 4 Dexamethasone 4 Cyclophosphamide 4 Blood Specimen Collection 4 Prednisone 3 Melphalan 3 Biopsy, Fine-Needle 3 fluciclovine F-18 2 carfilzomib 2 Surveys and Questionnaires 2 Positron-Emission Tomography 2 Mammography 2 Lenalidomide 2 Injections 2 Immunohistochemistry 2 Gemcitabine 2 Cytarabine 2 weifuchun 1 vistusertib 1 venetoclax 1 ricolinostat 1 pomalidomide 1 phosphoribosylformylglycinamidine synthetase 1 pembrolizumab 1 ofatumumab 1 obinutuzumab 1 irinotecan sucrosofate 1 ibrutinib 1 gossypol acetic acid 1 glycidol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02865239 2018-08-08

EFIMED

Institut de Cancérologie de Lorraine

Phase NA Completed

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡